መነሻ540222 • BOM
add
Laurus Labs Ltd
የቀዳሚ መዝጊያ
₹572.70
የቀን ክልል
₹556.65 - ₹574.75
የዓመት ክልል
₹358.70 - ₹593.00
የገበያው አጠቃላይ ዋጋ
301.42 ቢ INR
አማካይ መጠን
92.76 ሺ
የዋጋ/ገቢ ምጥጥን
229.85
የትርፍ ክፍያ
0.14%
ዋና ልውውጥ
NSE
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
(INR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ገቢ | 12.24 ቢ | -0.06% |
የሥራ ወጪ | 6.05 ቢ | 10.51% |
የተጣራ ገቢ | 198.40 ሚ | -46.31% |
የተጣራ የትርፍ ክልል | 1.62 | -46.36% |
ገቢ በሼር | 0.37 | -45.59% |
EBITDA | 1.78 ቢ | -5.65% |
ውጤታማ የግብር ተመን | 20.33% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
(INR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 449.20 ሚ | -33.11% |
አጠቃላይ ንብረቶች | 87.29 ቢ | 8.34% |
አጠቃላይ ተጠያቂነቶች | 45.85 ቢ | 14.21% |
አጠቃላይ እሴት | 41.44 ቢ | — |
የሼሮቹ ብዛት | 536.22 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 7.43 | — |
የእሴቶች ተመላሽ | — | — |
የካፒታል ተመላሽ | 2.60% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
(INR) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
---|---|---|
የተጣራ ገቢ | 198.40 ሚ | -46.31% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | — | — |
ገንዘብ ከኢንቨስትመንት | — | — |
ገንዘብ ከፋይናንስ | — | — |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | — | — |
ነፃ የገንዘብ ፍሰት | — | — |
ስለ
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
2005
ድህረገፅ
ሠራተኞች
6,007